Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Special Report: Predictive cancer diagnostics company Rhythm Biosciences (ASX:RHY) is ending 2024 on a high reporting it had ...

Bowel cancer, also known as colorectal cancer, is an aggressive cancer with a high incidence in developed countries.

Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia.

Most indoor-garden kits use either a self-watering or hydroponic system to grow plants. I started with a self-watering system — the Click-and-Grow model — and after years of testing ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

While bowel cancer – or colorectal cancer – has traditionally ... an alarming reminder to take up any offers of bowel cancer screening and treat any symptoms seriously. Yet having bowel ...

notes that the diagnosis rate and the death rate for colorectal cancer has been decreasing in the United States since the 1980s. The ACS attributes the decline to increased screening and ...